What are the differences in presentation, age, clinical features, and pathology between infectious mononucleosis, tubercular (tuberculosis) lymphadenopathy, Diffuse Large B-Cell Lymphoma (DLBCL), follicular lymphoma, marginal zone lymphoma, Hodgkin lymphoma, and Human Immunodeficiency Virus (HIV) lymphadenopathy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Comparison of Lymphadenopathies: Infectious Mononucleosis, Tubercular Lymphadenopathy, Lymphomas, and HIV Lymphadenopathy

The most critical distinguishing features between these conditions are age of presentation, pattern of lymphadenopathy, specific clinical symptoms, and characteristic pathological findings including immunophenotyping and molecular markers.

Infectious Mononucleosis

Presentation and Age

  • Typically affects adolescents and young adults (median age 18 years)
  • Acute onset with sore throat, cervical lymph node enlargement, fatigue, and fever lasting several weeks 1

Clinical Features

  • Triad of fever, pharyngitis, and lymphadenopathy
  • Splenomegaly in 50% of cases
  • Palatal petechiae and periorbital edema may be present
  • Fatigue may persist for weeks to months

Pathology

  • Polymorphous infiltrate with immunoblastic proliferation
  • Reed-Sternberg-like cells present in 44% of cases
  • Necrosis (56%) and mucosal ulceration (40%) may be present
  • Immunoblasts are CD20+ B cells with post-germinal center immunophenotype:
    • MUM1/IRF4 strongly positive (100%)
    • CD10 negative (100%)
    • BCL-6 negative (89%)
    • Variable weak BCL-2 expression
    • Polyclonal κ and λ immunoglobulin light chains (81%)
    • Reed-Sternberg-like cells are CD30+, CD15-, BOB.1+, OCT-2+ 2

Tubercular Lymphadenopathy

Presentation and Age

  • Can affect any age group, but most common in young adults (20-40 years)
  • Subacute to chronic presentation

Clinical Features

  • Painless, firm, matted lymph nodes, most commonly cervical (scrofula)
  • Constitutional symptoms: low-grade fever, weight loss, night sweats
  • May have concurrent pulmonary or extrapulmonary TB

Pathology

  • Three main cytomorphological patterns:
    • Caseation necrosis with ill-formed granulomas
    • Well-formed epithelioid granulomas with or without necrosis
    • Reactive hyperplasia with caseation necrosis
  • Acid-fast bacilli (AFB) positivity highest in nodes with caseation necrosis
  • Culture on Löwenstein-Jensen medium more sensitive than Ziehl-Neelsen staining 3

Diffuse Large B-Cell Lymphoma (DLBCL)

Presentation and Age

  • Median age 60-70 years, but can occur at any age
  • Constitutes 30-58% of non-Hodgkin lymphomas 4

Clinical Features

  • Rapidly enlarging, non-tender lymphadenopathy
  • B symptoms (fever, night sweats, weight loss) in 30% of cases
  • Extranodal involvement in 40% of cases

Pathology

  • Diffuse infiltrate of large cells erasing normal lymph node architecture
  • Immunophenotype:
    • CD20+, CD79a+ B cells
    • Variable expression of CD10, BCL6, and BCL2
    • Classified as germinal center B-cell-like (GCB) or activated B-cell-like (ABC) subtypes
    • Hans algorithm uses CD10, BCL6, and MUM1 for classification
  • Molecular subtypes:
    • MYC rearrangements in 10%
    • BCL2 rearrangements in 20-30%
    • BCL6 rearrangements in 30%
    • "Double-hit" or "triple-hit" lymphomas have concurrent MYC and BCL2 and/or BCL6 rearrangements 4, 5

Follicular Lymphoma

Presentation and Age

  • Median age 60 years
  • Indolent course with waxing and waning lymphadenopathy

Clinical Features

  • Painless, widespread lymphadenopathy
  • B symptoms uncommon at presentation
  • Bone marrow involvement in 70% of cases

Pathology

  • Follicular pattern with effacement of normal architecture
  • Mixture of centrocytes (small cleaved cells) and centroblasts (large cells)
  • Graded 1-3 based on proportion of centroblasts
  • Immunophenotype:
    • CD20+, CD10+, BCL2+, BCL6+
    • CD5-, CD43-, cyclin D1-
    • t(14;18) translocation involving BCL2 in 85-90% of cases 4

Marginal Zone Lymphoma

Presentation and Age

  • Median age 60 years
  • Indolent course

Clinical Features

  • Depends on subtype:
    • MALT lymphoma: extranodal sites (stomach, lung, thyroid)
    • Nodal MZL: painless lymphadenopathy
    • Splenic MZL: splenomegaly, peripheral blood involvement

Pathology

  • Expansion of marginal zone with medium-sized B cells
  • Monocytoid appearance with abundant pale cytoplasm
  • Immunophenotype:
    • CD20+, BCL2+
    • CD5-, CD10-, BCL6-, cyclin D1-
    • May have t(11;18), t(1;14), t(14;18) involving MALT1, or t(3;14) 4

Hodgkin Lymphoma

Presentation and Age

  • Bimodal age distribution: 15-35 years and >50 years
  • More common in males

Clinical Features

  • Painless, firm lymphadenopathy, often cervical or mediastinal
  • B symptoms in 30% of cases
  • Pruritus may be present

Pathology

  • Classic Hodgkin lymphoma:
    • Reed-Sternberg cells in inflammatory background
    • Immunophenotype: CD30+, CD15+, PAX5 weak+, CD20-/+, CD45-
  • Nodular lymphocyte predominant Hodgkin lymphoma:
    • Lymphocyte predominant cells ("popcorn cells")
    • Immunophenotype: CD20+, CD45+, BCL6+, CD30-, CD15- 4

HIV Lymphadenopathy

Presentation and Age

  • Affects HIV-infected individuals of any age
  • Presentation varies with CD4+ count

Clinical Features

  • Persistent generalized lymphadenopathy (PGL) common in early HIV
  • Opportunistic infections and malignancies more common with declining CD4+ counts
  • Lymphadenopathy etiologies correlate with CD4+ count:
    • CD4+ >500: Reactive hyperplasia
    • CD4+ 200-500: Tuberculosis, lymphomas
    • CD4+ <200: Atypical mycobacteria, fungal infections
    • CD4+ <50: Mycobacterium avium complex (MAC) 4, 3

Pathology

  • Four main cytomorphological patterns:
    • Reactive hyperplasia with follicular hyperplasia
    • Caseation necrosis (TB or atypical mycobacteria)
    • Well-formed granulomas (histoplasmosis, cryptococcosis)
    • Lymphoma (primarily DLBCL or Burkitt lymphoma)
  • HIV-associated DLBCL:
    • More frequently non-GCB subtype
    • Often EBV-positive
    • May have concurrent HCV infection 4, 3, 6

Key Distinguishing Features

  1. Age distribution:

    • Infectious mononucleosis: Adolescents and young adults
    • Tubercular lymphadenopathy: Young adults
    • DLBCL and other lymphomas: Older adults (except Burkitt and HIV-associated)
    • HIV lymphadenopathy: Any age with HIV infection
  2. Lymph node characteristics:

    • Infectious mononucleosis: Tender, mobile cervical nodes
    • Tubercular lymphadenopathy: Firm, matted, often with sinus formation
    • DLBCL: Rapidly enlarging, firm nodes
    • Follicular lymphoma: Multiple sites, waxing and waning
    • Hodgkin lymphoma: Rubbery, painless, often cervical or mediastinal
  3. Pathological hallmarks:

    • Infectious mononucleosis: Polymorphous infiltrate, MUM1+/CD10-/BCL6- immunoblasts
    • Tubercular lymphadenopathy: Caseating granulomas, AFB+
    • DLBCL: Diffuse large cell infiltrate, CD20+
    • Follicular lymphoma: Follicular pattern, t(14;18), CD10+/BCL2+/BCL6+
    • Marginal zone lymphoma: Marginal zone expansion, CD20+/CD5-/CD10-
    • Hodgkin lymphoma: Reed-Sternberg cells, CD30+/CD15+
    • HIV lymphadenopathy: Variable, depends on etiology and CD4+ count

Clinical Approach to Differential Diagnosis

  1. First, assess patient age and HIV status:

    • Young adult with acute onset: Consider infectious mononucleosis
    • HIV-positive patient: Consider HIV-related causes based on CD4+ count
    • Older adult: Higher suspicion for lymphoma
  2. Evaluate pattern and distribution of lymphadenopathy:

    • Localized vs. generalized
    • Presence of B symptoms
    • Associated organomegaly
  3. Perform appropriate diagnostic tests:

    • Complete blood count with differential
    • Monospot or EBV serology for suspected mononucleosis
    • HIV testing if status unknown
    • CD4+ count if HIV-positive
    • Excisional biopsy for definitive diagnosis (FNA alone insufficient) 4
  4. Pathological evaluation should include:

    • Histomorphology
    • Immunohistochemistry panel: CD20, CD3, CD5, CD10, BCL2, BCL6, cyclin D1, CD21/CD23
    • Flow cytometry: kappa/lambda, CD19, CD20, CD5, CD23, CD10
    • Molecular studies as indicated: FISH for translocations, PCR for clonality 4

Remember that Reed-Sternberg-like cells can be seen in both infectious mononucleosis and Hodgkin lymphoma, making immunophenotyping crucial for differentiation (CD15- in mononucleosis, CD15+ in Hodgkin lymphoma) 2.

References

Research

Infectious Mononucleosis.

Current topics in microbiology and immunology, 2015

Research

Infectious mononucleosis mimicking lymphoma: distinguishing morphological and immunophenotypic features.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2012

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnosis and Treatment of High-Grade B-Cell Lymphoma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pathology of lymphoma in HIV.

Current opinion in oncology, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.